CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,593,541
+10.9%
468,206
+7.5%
0.00%
+50.0%
Q2 2023$8,650,802
+18.1%
435,370
+1.8%
0.00%0.0%
Q1 2023$7,323,400
-11.4%
427,519
+1.3%
0.00%
-33.3%
Q4 2022$8,261,965
+50.8%
422,175
+23.0%
0.00%
+50.0%
Q3 2022$5,479,000
+22.7%
343,264
+5.7%
0.00%0.0%
Q2 2022$4,467,000
-12.9%
324,607
+0.4%
0.00%0.0%
Q1 2022$5,126,000
-24.3%
323,172
+4.2%
0.00%0.0%
Q4 2021$6,771,000
-25.3%
310,133
+2.3%
0.00%
-33.3%
Q3 2021$9,066,000
-31.1%
303,304
+2.1%
0.00%
-25.0%
Q2 2021$13,155,000
+5.4%
297,015
+5.6%
0.00%
-20.0%
Q1 2021$12,485,000
-12.6%
281,379
+8.0%
0.01%
-16.7%
Q4 2020$14,288,000
+166.6%
260,536
+11.1%
0.01%
+200.0%
Q3 2020$5,360,000
+10.4%
234,455
+1.1%
0.00%0.0%
Q2 2020$4,856,000
+66.9%
232,006
+11.2%
0.00%0.0%
Q1 2020$2,910,000
-35.9%
208,552
+4.6%
0.00%0.0%
Q4 2019$4,537,000
+107.1%
199,333
+6.0%
0.00%
+100.0%
Q3 2019$2,191,000
-21.4%
187,987
+1.1%
0.00%
-50.0%
Q2 2019$2,788,000
+8.9%
185,859
+27.4%
0.00%0.0%
Q1 2019$2,560,000
+32.6%
145,942
+12.1%
0.00%
+100.0%
Q4 2018$1,930,000
-36.9%
130,220
+4.8%
0.00%
-50.0%
Q3 2018$3,058,000
+268.0%
124,200
+193.6%
0.00%
+100.0%
Q2 2018$831,00042,2990.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders